2014年非酒精性脂肪性肝病诊治进展*

doi:10.3969/j.issn.1672-5069.2015.01.003

实用肝脏病杂志 ›› 2015, Vol. 18 ›› Issue (1): 6-9.doi: 10.3969/j.issn.1672-5069.2015.01.003

2014年非酒精性脂肪性肝病诊治进展^*

荀运浩, 施军平

310023 杭州市西溪医院（荀运浩）; 杭州师范大学附属医院（施军平）

收稿日期:2014-11-05 出版日期:2015-12-17 发布日期:2015-12-17
基金资助:
杭州市科技发展计划项目（2014Q40/ 2007Q04）

Progress in the diagnosis and management of nonalcoholic fatty liver disease

Xun Yunhao, Shi Junping

Department of Liver Diseases,Xixi Hospital,Hangzhou 310023,China

Received:2014-11-05 Online:2015-12-17 Published:2015-12-17

摘要/Abstract

关键词: 非酒精性脂肪性肝病, 诊断, 治疗, 进展

Key words: Nonalcoholic fatty liver disease, Diagnosis, Treatment, Progress

荀运浩, 施军平. 2014年非酒精性脂肪性肝病诊治进展^*[J]. 实用肝脏病杂志, 2015, 18(1): 6-9.

Xun Yunhao, Shi Junping. Progress in the diagnosis and management of nonalcoholic fatty liver disease[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(1): 6-9.

[1] Obesity:a growing threat to health in China. Lancet,2014,384:716.
[2] Yeh MM,Brunt EM. Pathological features of fatty liver disease. Gastroenterology,2014,147:754-764.
[3] Musso G,Gambino R,Cassader M,et al. Meta-analysis:natural history of non-alcoholic fatty liver disease（NAFLD） and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med,2011,43:617-649.
[4] Joka D,Wahl K,Moeller S,et al. Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis. Hepatology,2012,55:455-464.
[5] 钱建成,陆璐,娄国强,等. 血清细胞角蛋白18诊断非酒精性脂肪性肝病的价值探讨. 实用肝脏病杂志,2012,15（4）:291-294.
[6] Chan WK,Sthaneshwar P,Nik Mustapha NR,et al. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis a comparison with routine biochemical markers. PLoS One,2014,9:e105903.
[7] Chen J,Zhu Y,Zheng Q,et al. Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis:A meta-analysis. Hepatol Res,2014,44:854-862.
[8] Otgonsuren M,Estep MJ,Hossain N,et al. A single non-invasive model to diagnose non-alcoholic fatty liver disease （NAFLD） and non-alcoholic steatohepatitis（NASH）. J Gastroenterol Hepatol,2014,Jul 6. doi:10.1111/jgh.12665.[Epub ahead of print].
[9] Bastati N,Feier D,Wibmer A,et al. Noninvasive differentiation of simple steatosis and steatohepatitis by using gadoxetic acid-enhanced MR imaging in patients with nonalcoholic fatty liver disease:a proof-of-concept study. Radiology,2014,271:739-747.
[10] Issa L,Goh GB,Lopez R,et al. The development of a non-invasive model to predict the presence of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease. Hepatology,2014,57 （Suppl 1）:883A.
[11] Chalasani N,Younossi Z,Lavine JE,et al. The diagnosis and management of non-alcoholic fatty liver disease:practice guideline by the American Gastroenterological Association,American Association for the Study of Liver Diseases,and American College of Gastroenterology. Gastroenterology,2012,142:1592-1609.
[12] Musso G,Cassader M,Rosina F,et al. Impact of current treatments on liver disease,glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease（NAFLD）:a systematic review and meta-analysis of randomised trials. Diabetologia,2012,55:885-904.

[1]	鲍应军, 任伟新. 门静脉血栓介入治疗研究进展[J]. 实用肝脏病杂志, 2019, 22(6): 768-769.
[2]	中国研究型医院学会肝病专业委员会, 中国医师协会脂肪性肝病专家委员会. 脂肪性肝病诊疗规范化的专家建议（2019年修订版）[J]. 实用肝脏病杂志, 2019, 22(6): 787-792.
[3]	. 肝纤维化诊断及治疗共识（2019年）[J]. 实用肝脏病杂志, 2019, 22(6): 793-803.
[4]	任俞霏, 陈小青, 孔维宗, 王迎春. 丹酚酸B对非酒精性脂肪性肝病细胞模型自噬功能的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 804-807.
[5]	石莹莹, 王元喜. 替比夫定联合阿德福韦酯治疗慢性乙型肝炎患者效果及其对肾功能的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 820-823.
[6]	吴海义, 陈建新. 四种诊断模型诊断乙型肝炎病毒携带者肝纤维化的效能分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 832-835.
[7]	李颖怡, 郭翠芬, 章瑞南, 汪保灿, 潘勤, 汪余勤, 曹海霞, 范建高. ALDH2 rs671基因多态性与非酒精性脂肪性肝病相关性研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 848-851.
[8]	邢欣, 魏重操, 周咪咪, 李小玲, 邓江, 鲁晓岚. 牛磺熊去氧胆酸与熊去氧胆酸治疗非酒精性脂肪性肝病患者疗效和安全性的Meta分析[J]. 实用肝脏病杂志, 2019, 22(6): 852-855.
[9]	段楚瑶, 陈庆山, 汪黎明, 贺晓琪. 熊去氧胆酸治疗妊娠期肝内胆汁淤积症患者疗效研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 864-867.
[10]	陈梅梅, 段晓燕, 曹海霞, 丁雯瑾. 复方鳖甲软肝片治疗原发性胆汁性肝硬化患者疗效分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 880-883.
[11]	马雅琼, 李芝兰, 夏冰. 早期肠内营养联合微生态制剂治疗肝性脑病患者肠道菌群的改变^*[J]. 实用肝脏病杂志, 2019, 22(6): 892-895.
[12]	曹策, 郁义星, 王贝贝, 赵卫峰. 增强磁共振成像联合血清甲胎蛋白和脱-γ-羧基凝血酶原诊断肝细胞癌临床价值探讨[J]. 实用肝脏病杂志, 2019, 22(6): 896-899.
[13]	曾艳妮, 张灿, 毕俊英, 刘良进, 孟俊, 秦涛. MRI长时间延迟增强扫描诊断肝脏孤立性坏死性结节价值研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 900-903.
[14]	冯文广, 姜伟, 宋国军. PPV指导术中液体治疗对行肝部分切除术治疗的肝内胆管结石患者术后并发症发生的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 912-915.
[15]	黎秋曦, 贾健锋, 黄锐. 区段肝蒂肝切除术与B超引导下肝切除术治疗肝胆管结石患者临床价值分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 916-919.

2014年非酒精性脂肪性肝病诊治进展^*

Progress in the diagnosis and management of nonalcoholic fatty liver disease

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价